Investigator site selection is a critical element of a successful clinical trial. Clinilabs Drug Development Corporation offers an expansive network of investigator sites in 42 countries, with a robust operational infrastructure that supports international multicenter trials and independent, engaged investigators who have been pre-identified for their access to patients with CNS disorders, providing your study with a virtual waiting room. Clinilabs has deep-rooted, long-standing relationships with these researchers, who consistently exceed expectations for subject accrual and diversity, data quality, and timelines while maintaining a patient-centric approach.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
– George W. Merck